Background
B-acute lymphoblastic leukemia (B-ALL) is a heterogeneous disease comprising more than 20 molecular subtypes defined by distinct gene expression profiles (GEPs) and genetic alterations. Subtypes primarily defined by GEPs remain challenging to identify using conventional cytogenetic and targeted molecular ass...
Seoyoung Lim, Yu Jeong Choi, Yu Jin Park et al.· Annals of Laboratory Medicin...· 0 citations
Circulating tumor DNA (ctDNA) is a minimally invasive biomarker in pancreatic ductal adenocarcinoma (PDAC), but the prognostic information added by multigene ctDNA metrics beyond KRAS and carbohydrate antigen 19-9 (CA19-9) is uncertain. In this prospective observational pilot study, 51 patients with advanced PDAC recei...
Gi-Ye-On Lee, Jung Won Chun, Dong-eun Lee et al.· International Journal of Mol...· 0 citations
PURPOSE
To delineate the clinical and genetic spectrum of EYS-associated retinal degeneration (EYS-RD) and to quantify longitudinal progression of retinal structure and visual function.
DESIGN, SETTING, AND PARTICIPANTS
Multicenter retrospective cohort study at eight tertiary referral centers in South Korea, enrollin...
Jehwi Jeon, Dongheon Surl, H. Park et al.· American journal of ophthalm...· 0 citations
Overall, the findings suggest that panel-based ultra-deep NGS improves mutation detection, enhances diagnostic sensitivity, and may provide valuable prognostic information for MPN management, although larger prospective studies are needed to confirm these results.
Namsoo Kim, Yehyun Kang, H. W. Kook et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.